
Keywords: physical signs; pathophysiology; treatment; BMT; Bone marrow transplantation; CyA; Cyclosporine A; HCQ; Hydroxychloroquine; HLA; Human leukocyte antigen; IL; Interleukin; IVIG; Intravenous immunoglobulin therapy; JDM; Juvenile dermatomyositis; JM; Juvenil